Literature DB >> 30138052

Going for Broke: A Longitudinal Study of Patient-Reported Financial Sacrifice in Cancer Care.

Fumiko Chino1, Jeffrey M Peppercorn1, Christel Rushing1, Jonathan Nicolla1, Arif H Kamal1, Ivy Altomare1, Greg Samsa1, S Yousuf Zafar1.   

Abstract

PURPOSE: Patients with cancer are at risk for substantial treatment-related costs; however, little is known about patients' willingness to sacrifice to receive cancer care and how their attitudes and burden may change with time. PATIENTS AND METHODS: We conducted a longitudinal survey of insured patients with solid tumor cancers receiving chemotherapy or hormonal therapy. Patients were surveyed at two time points about their willingness to make financial sacrifices and their actual sacrifices, including out-of-pocket costs. Patient attitudes and sacrifices were compared over time.
RESULTS: Of 349 patients approached, 300 completed the baseline survey (86% response) and 245 completed the follow-up survey 3 months later (82% retention). Median patient-reported cancer-related out-of-pocket costs for patients who completed both surveys were $393 per month (range, $0 to $26,586 per month) at baseline and $328 per month (range, $0 to $8,210 per month) at follow-up. At baseline, 49% were willing to declare personal bankruptcy, 38% were willing to sell their homes, and ≥ 65% were willing to make other sacrifices, including borrowing money to afford their cancer care. Upon follow-up, there were minor decreases in willingness; the maximum net change was a 7% decline in patients willing to declare bankruptcy. Actual sacrifice increased over time; the greatest increase was in patients who used their savings (increased from 41% to 54%).
CONCLUSION: A large proportion of insured patients with cancer were willing to make considerable personal and financial sacrifices to receive care; these attitudes did not change greatly over time. Shared decision making is important to ensure patients fully understand the goals, risks, and benefits of therapy before they make such personal sacrifices.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30138052      PMCID: PMC6550053          DOI: 10.1200/JOP.18.00112

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN: 1554-7477            Impact factor:   3.840


  12 in total

1.  Financial burden of cancer care under the Affordable Care Act: Analysis of MEPS-Experiences with Cancer Survivorship 2011 and 2016.

Authors:  Young-Rock Hong; Grace L Smith; Zhigang Xie; Arch G Mainous; Jinhai Huo
Journal:  J Cancer Surviv       Date:  2019-06-10       Impact factor: 4.442

Review 2.  Review of Current Policy Strategies to Reduce US Cancer Drug Costs.

Authors:  Angela K Green; Jennifer A Ohn; Peter B Bach
Journal:  J Clin Oncol       Date:  2019-12-05       Impact factor: 44.544

3.  Financial Hardship in Adolescent and Young Adult Oncology: The Need for Multidimensional and Multilevel Approaches.

Authors:  John M Salsman; Sheetal M Kircher
Journal:  JCO Oncol Pract       Date:  2021-11-22

4.  What Oncologists Must Account for: The Financial Burden of Cancer-Associated Symptom Relief.

Authors:  Fantine Giap; Fumiko Chino
Journal:  JCO Oncol Pract       Date:  2021-11-30

Review 5.  The Out-of-Pocket Cost Burden of Cancer Care-A Systematic Literature Review.

Authors:  Nicolas Iragorri; Claire de Oliveira; Natalie Fitzgerald; Beverley Essue
Journal:  Curr Oncol       Date:  2021-03-15       Impact factor: 3.677

Review 6.  Financial toxicity associated with treatment of localized prostate cancer.

Authors:  Brandon S Imber; Melissa Varghese; Behfar Ehdaie; Daniel Gorovets
Journal:  Nat Rev Urol       Date:  2019-12-02       Impact factor: 14.432

7.  Systematic review of financial burden assessment in cancer: Evaluation of measures and utility among adolescents and young adults and caregivers.

Authors:  John M Salsman; Suzanne C Danhauer; Justin B Moore; Edward H Ip; Laurie E McLouth; Chandylen L Nightingale; Christabel K Cheung; Kristin M Bingen; Reginald D Tucker-Seeley; Denisha Little-Greene; Dianna S Howard; Bryce B Reeve
Journal:  Cancer       Date:  2021-04-13       Impact factor: 6.921

8.  Measuring Financial Distress and Quality of Life Over Time in Patients With Gynecologic Cancer-Making the Case to Screen Early in the Treatment Course.

Authors:  Margaret I Liang; Sarah S Summerlin; Christina T Blanchard; Teresa K L Boitano; Warner K Huh; Smita Bhatia; Maria Pisu
Journal:  JCO Oncol Pract       Date:  2021-02-17

9.  Cancer's Lasting Financial Burden: Evidence From a Longitudinal Assessment.

Authors:  Ya-Chen Tina Shih; Kelsey M Owsley; Lauren Hersch Nicholas; K Robin Yabroff; Cathy J Bradley
Journal:  J Natl Cancer Inst       Date:  2022-07-11       Impact factor: 11.816

Review 10.  Cancer medicines in Asia and Asia-Pacific: What is available, and is it effective enough?

Authors:  Alexandru Eniu; Nathan I Cherny; Melanie Bertram; Sumitra Thongprasert; Jean-Yves Douillard; Gracemarie Bricalli; Malvika Vyas; Dario Trapani
Journal:  ESMO Open       Date:  2019-07-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.